U.S. Markets closed
  • S&P 500

    4,577.10
    +64.06 (+1.42%)
     
  • Dow 30

    34,639.79
    +617.75 (+1.82%)
     
  • Nasdaq

    15,381.32
    +127.27 (+0.83%)
     
  • Russell 2000

    2,206.33
    +58.91 (+2.74%)
     
  • Crude Oil

    67.44
    +0.94 (+1.41%)
     
  • Gold

    1,770.90
    +8.20 (+0.47%)
     
  • Silver

    22.43
    +0.12 (+0.53%)
     
  • EUR/USD

    1.1306
    -0.0017 (-0.1470%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3301
    +0.0023 (+0.1742%)
     
  • USD/JPY

    113.0870
    +0.3070 (+0.2722%)
     
  • BTC-USD

    56,646.67
    -526.07 (-0.92%)
     
  • CMC Crypto 200

    1,450.10
    +11.22 (+0.78%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,753.37
    -182.25 (-0.65%)
     

Johnson & Johnson’s Stock Deserves a Booster

Johnson & Johnson’s Stock Deserves a Booster
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Wall Street’s excessive focus on vaccine sales has created an opportunity for investors to buy J&J shares at a discount.